People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kalytera Therapeutics, Inc. | — | Pharma | Pre-Seed | $2.2M | $35.9M | 2017 |
SARI PRUTCHI-SAGIV at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside SARI PRUTCHI-SAGIV on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jerome Zeldis | 1 | 6 |
| Robert Farrell | 1 | 4 |
| Jeff Paley | 1 | 3 |
| David Stefansky | 1 | 3 |
| Ronald Erickson | 1 | 2 |
| Seth Yakatan | 1 | 2 |
| RONEN RAVIV | 1 | 1 |
| MOSHE YESHURUN | 1 | 1 |
| Jeffrey Paley | 1 | 1 |
| Victoria Rudman | 1 | 1 |
| Farrell Robert | 1 | 1 |
| Robin Hutchison | 1 | 1 |
| Gary Leong | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.